Prasówka Newsy Inne Polatuzumab Vedotin Boosts Survival in Relapsed DLBCLPolatuzumab Vedotin Boosts Survival in Relapsed DLBCL📅 09.07.2026, 12:48📰 Medscape⭐ Ważność: 5/10🏷️ InneBrak treści.Źródło: MedscapeKategoria: InneWażność: ⭐⭐⭐⭐⭐ (5/10)📎 Powiązane artykułyCongo Ebola Response Workers Protest Over Pay 09.07MRI Enhancement Predicts Breast Cancer in BRCA Carriers 09.07Is Alzheimer’s Research Focusing on the Wrong Target? 09.07Limited Data for JAK Inhibitors in SSc Described in Study 09.07Abrocitinib Boosts Skin Clearance and Itch Relief in AD 09.07